This is a firm fixed-price purchase order award to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products, for the delivery of Impavido/Miltefosine capsules and tablets. The award, valued at $99,900.00, was made by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA). Profounda Inc. specializes in producing and distributing this critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. The contract has no set-aside designation and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) that Profounda Inc. holds with the VA's Veterans Health Administration, specifically with VISN 8. This BPA allows the company to pre-position Impavido/Miltefosine at VA medical centers within the network, facilitating expedited access and treatment for urgent cases.
Generated 3/13/25, 10:08 AM